Nilutamide
Product manufactured by Prasco Laboratories
Indications and Purposes
| Indications & Usage Metastatic Prostate Cancer Nilutamide Tablets Are Indicated For Use In Combination With Surgical Castration For The Treatment Of Metastatic Prostate Cancer (Stage D 2 ). For Maximum Benefit, Nilutamide Treatment Must Begin On The Same Day As Or On The Day After Surgical Castration. |
All Formulated Excipients (0 Total)
None
Active Ingredients ( 1 Total)
| Name | Structure | ZINC ID(s) |
|---|---|---|
| 1. Nilutamide |
|
ZINC3874498 |